16-Methoxytabersonine
| Names | |
|---|---|
| IUPAC name
Methyl 16-methoxy-2,3,6,7-tetradehydro-5α,12β,19α-aspidospermidine-3-carboxylate | |
| Systematic IUPAC name
Methyl (3aR,3a1S,10bS)-3a-ethyl-8-methoxy-3a,3a1,4,6,11,12-hexahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate | |
| Other names
Ervamycine | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C22H26N2O3 | |
| Molar mass | 366.461 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
16-Methoxytabersonine is a terpene indole alkaloid produced by the medicinal plant Catharanthus roseus. 16-methoxytabersonine is synthesized by methylation of the hydroxyl group at the 16 position of 16-hydroxytabersonine by tabersonine 16-O-methyltransferase (16OMT). The compound is a substrate for hydration by two concerted enzymes Tabersonine-3-Oxidase (T3O) and Tabersonine-3-Reductase (T3R), which leads to the formation of 3-hydroxy-16-methoxy-2,3-dihydrotabersonine.